Alpha 2.0
Login Register
» Authors » L N van Steenbergen

L N van Steenbergen

Explore the profile of L N van Steenbergen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 22
Citations 286
Followers 0
Related Specialties
Oncology
General Surgery
Orthopedics
Top 10 Co-Authors
V E P P Lemmens
H J T Rutten
J W W Coebergh
M L G Janssen-Heijnen
D J van Spronsen
J A Roukema
L V van de Poll-Franse
A C Voogd
G A P Nieuwenhuijzen
V C G Tjan-Heijnen
Published In
Ann Oncol
Eur J Surg Oncol
Eur J Cancer
Int J Colorectal Dis
Cancer Epidemiol
Affiliations
Soon will be listed here.
Recent Articles
1.
Fast Starters, Slow Starters, and Late Dippers: Trajectories of Patient-Reported Outcomes After Total Hip Arthroplasty: Results from a Dutch Nationwide Database
Hesseling B, Mathijssen N, van Steenbergen L, Melles M, Vehmeijer S, Porsius J
J Bone Joint Surg Am . 2019 Oct; 101(24):2175-2186. PMID: 31609887
Background: The purpose of this study was to explore whether subgroups of patients with different functional recovery trajectories after total hip arthroplasty can be discerned, as well as their predictors,...
2.
The risk of revision after total hip arthroplasty in young patients depends on surgical approach, femoral head size and bearing type; an analysis of 19,682 operations in the Dutch arthroplasty register
Kuijpers M, Hannink G, Vehmeijer S, van Steenbergen L, Schreurs B
BMC Musculoskelet Disord . 2019 Aug; 20(1):385. PMID: 31438921
Background: Total hip arthroplasty (THA) is used increasingly in younger patients. There is little knowledge about the effect of THA characteristics on risk of revision, especially in young patients. Therefore,...
3.
Determinants in decision making for curative treatment and survival in patients with resectable oesophageal cancer in the Netherlands: a population-based study
Koeter M, van Steenbergen L, Lemmens V, Rutten H, Roukema J, Nieuwenhuijzen G
Cancer Epidemiol . 2015 Dec; 39(6):863-9. PMID: 26651448
Background: Preferred treatment for resectable oesophageal cancer is surgery with or without neoadjuvant treatment. However, oesophageal surgery has high morbidity and in vulnerable patients with co-morbidity other treatment modalities can...
4.
Conditional survival for long-term colorectal cancer survivors in the Netherlands: who do best?
van Erning F, van Steenbergen L, Lemmens V, Rutten H, Martijn H, van Spronsen D, et al.
Eur J Cancer . 2014 May; 50(10):1731-1739. PMID: 24814358
Aim: With the increase in the number of long-term colorectal cancer (CRC) survivors, there is a growing need for subgroup-specific analysis of conditional survival. Methods: All 137,030 stage I-III CRC...
5.
Hospital of diagnosis and probability to receive a curative treatment for oesophageal cancer
Koeter M, van Steenbergen L, Lemmens V, Rutten H, Roukema J, Wijnhoven B, et al.
Eur J Surg Oncol . 2014 Feb; 40(10):1338-45. PMID: 24484779
Background: Surgical treatment of oesophageal cancer in the Netherland is performed in high volume centres. However, the decision to refer patients for curative surgery is made in the referring hospital...
6.
Time trends and inter-hospital variation in treatment and axillary staging of patients with ductal carcinoma in situ of the breast in the era of screening in Southern Netherlands
van Steenbergen L, Voogd A, Roukema J, Louwman W, Duijm L, Coebergh J, et al.
Breast . 2013 Dec; 23(1):63-8. PMID: 24291376
Background: To examine variation in time and place in axillary staging and treatment of patients with ductal carcinoma in situ (DCIS) of the breast. Methods: Trends in patients with DCIS...
7.
Small but significant excess mortality compared with the general population for long-term survivors of breast cancer in the Netherlands
Janssen-Heijnen M, van Steenbergen L, Voogd A, Tjan-Heijnen V, Nijhuis P, Poortmans P, et al.
Ann Oncol . 2013 Nov; 25(1):64-8. PMID: 24201973
Background: Coinciding with the relatively good and improving prognosis for patients with stage I-III breast cancer, late recurrences, new primary tumours and late side-effects of treatment may occur. We gained...
8.
No difference between lowest and highest volume hospitals in outcome after colorectal cancer surgery in the southern Netherlands
van Erning F, van Steenbergen L, van den Broek W, Rutten H, Lemmens V
Eur J Surg Oncol . 2013 Sep; 39(11):1199-206. PMID: 24044806
Aim: To investigate the quality of surgical colorectal cancer (CRC) care in the southern Netherlands by evaluating differences between the five hospitals with the lowest volume and the five hospitals...
9.
Diminishing differences in treatment between patients with colorectal cancer with and without diabetes: a population-based study
Zanders M, van Steenbergen L, Haak H, Rutten H, Pruijt J, Poortmans P, et al.
Diabet Med . 2013 Jun; 30(10):1181-8. PMID: 23758334
Aims: An increasing number of oncologists will be confronted with individuals having diabetes and cancer. We assessed changes in patient-, tumour- and treatment-related variables in patients with colorectal cancer with...
10.
Large variation between hospitals in follow-up for colorectal cancer in southern Netherlands
van Steenbergen L, de Hingh I, Rutten H, Rijk M, Orsini R, Coebergh J, et al.
Int J Colorectal Dis . 2013 Apr; 28(9):1257-65. PMID: 23624873
Purpose: The aims of the study were to describe the follow-up of colorectal cancer (CRC) patients in southern Netherlands and examine their overall and disease-free survival. Methods: Patients newly diagnosed...